[1]
|
Cho, J.H. (2008) The Genetics and Immunopathogenesis of Inflammatory Bowel Disease. Nature Reviews Immunology, 8, 458-466. https://doi.org/10.1038/nri2340
|
[2]
|
Gyde, S.N., Prior, P., Allan, R.N., et al. (1988) Colorectal Cancer in Ulcerative Colitis: A Cohort Study of Primary Referrals from Three Centres. Gut, 29, 206-217. https://doi.org/10.1136/gut.29.2.206
|
[3]
|
Isbell, G. and Levin, B. (1988) Ulcerative Colitis and Colon Cancer. Gastroenterology Clinics of North America, 17, 773-791.
|
[4]
|
Ekbom, A., Helmick, C., Zack, M., et al. (1990) Ulcer-ative Colitis and Colorectal Cancer. A Population-Based Study. The New England Journal of Medicine, 323, 1228-1233. https://doi.org/10.1056/NEJM199011013231802
|
[5]
|
Pia, A., Rainer, P., Michael, G., et al. (2002) Epigenetic Control of the E-Cadherin Gene (CDH1) by CpG Methylation in Colectomy Samples of Patients with Ulcerative Colitis. Genes Chromosomes & Cancer, 35, 121-126.
https://doi.org/10.1002/gcc.10101
|
[6]
|
Hofmann, M.A., Drury, S., Fu, C., et al. (1999) RAGE Mediates a Novel Proinflammatory Axis: A Central Cell Surface Receptor for S100/Calgranulin Polypeptides. Cell, 97, 889-901. https://doi.org/10.1016/S0092-8674(00)80801-6
|
[7]
|
Sparvero, L.J., Asafu-Adjei, D., Rui, K., et al. (2009) RAGE (Receptor for Advanced GlycationEndproducts), RAGE Ligands, and Their Role in Cancer and Inflammation. Journal of Translational Medicine, 7, 17.
https://doi.org/10.1186/1479-5876-7-17
|
[8]
|
Lutterloh, E.C., Opal, S.M., Pittman, D.D., et al. (2007) Inhibition of the RAGE Products Increases Survival in Experimental Models of Severe Sepsis and Systemic Infection. Critical Care, 11, R122. https://doi.org/10.1186/cc6184
|
[9]
|
van Zoelen, M.A., Schmidt, A.M., Florquin, S., et al. (2009) Receptor for Advanced Glycation End Products Facilitates Host Defense during Escherichia coli-Induced Abdominal Sepsis in Mice. The Journal of Infectious Diseases, 200, 765-773. https://doi.org/10.1086/604730
|
[10]
|
Chavakis, T., Bierhaus, A., Al-Fakhri, N., et al. (2003) The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leu-kocyte Integrins: A Novel Pathway for Inflammatory Cell Recruitment. Journal of Experimental Medicine, 198, 1507-1515. https://doi.org/10.1084/jem.20030800
|
[11]
|
Shi, F.Y., Ramasamy, R. and Schmidt, A.M. (2009) Re-ceptor for AGE (RAGE) & Its Ligands—Cast into Leading Roles in Diabetes & the Inflammatory Response. Journal of Molecular Medicine, 87, 235-247.
https://doi.org/10.1007/s00109-009-0439-2
|
[12]
|
Zen, K., Chen, C.X., Chen, Y.T., et al. (2007) Receptor for Ad-vanced Glycationendproducts Mediates Neutrophil Migration across Intestinal Epithelium. Journal of Immunology, 178, 2483-2490.
https://doi.org/10.4049/jimmunol.178.4.2483
|
[13]
|
Geetha, S., Jonamani, N., Bernd, W., et al. (2010) Carboxylated N-Glycans on RAGE Promote S100A12 Binding and Signaling. Journal of Cellular Biochemistry, 110, 645-659. https://doi.org/10.1002/jcb.22575
|
[14]
|
Jones, P.A. and Laird, P.W. (1999) Cancer-Epigenetics Comes of Age. Nature Genetics, 21, 163.
https://doi.org/10.1038/5947
|
[15]
|
Arisawa, T., Tahara, T., Shibata, T., et al. (2007) Promoter Hypomethylation of Protease-Activated Receptor 2 Associated with Carcinogenesis in the Stomach. Journal of Gastroenterology & Hepa-tology, 22, 943-948.
https://doi.org/10.1111/j.1440-1746.2007.04847.x
|
[16]
|
Lin, Z., Hegarty, J.P., Yu, W., et al. (2012) Identification of Disease-Associated DNA Methylation in B Cells from Crohn’s Disease and Ulcerative Colitis Patients. Digestive Diseases & Sciences, 57, 3145-3153.
https://doi.org/10.1007/s10620-012-2288-z
|
[17]
|
Saito, S., Kato, J., Hiraoka, S., et al. (2011) DNA Methylation of Colon Mucosa in Ulcerative Colitis Patients: Correlation with Inflammatory Status. Inflammatory Bowel Diseases, 17, 1955-1965. https://doi.org/10.1002/ibd.21573
|
[18]
|
Herman, J.G. and Baylin, S.B. (2003) Gene Silencing in Cancer in Association with Promoter Hypermethylation. New England Journal of Medicine, 349, 2042-2054. https://doi.org/10.1056/NEJMra023075
|
[19]
|
Feinberg, A.P. and Tycko, B. (2004) The History of Cancer Epige-netics. Nature Reviews Cancer, 4, 143-153.
https://doi.org/10.1038/nrc1279
|
[20]
|
Gunnar, E. and Nils, W. (2004) Epigenetics in Human Disease and Prospects for Epigenetic Therapy. Nature, 429, 457-463. https://doi.org/10.1038/nature02625
|
[21]
|
Esteller, M. (2005) Aberrant DNA Methylation as a Cancer-Inducing Mechanism. Annual Review of Pharmacology & Toxicology, 45, 629-656. https://doi.org/10.1146/annurev.pharmtox.45.120403.095832
|
[22]
|
Baylin, S.B., Herman, J.G., Graff, J.R., et al. (1998) Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia. Advances in Cancer Research, 72, 141-196. https://doi.org/10.1016/S0065-230X(08)60702-2
|
[23]
|
Kanai, Y. (2010) Genome-Wide DNA Methylation Profiles in Precancerous Conditions and Cancers. Cancer Science, 101, 36-45. https://doi.org/10.1111/j.1349-7006.2009.01383.x
|
[24]
|
Garritypark, M.M., Loftus, E.V.J., Sandborn, W.J., et al. (2010) Methylation Status of Genes in Non-Neoplastic Mucosa from Patients with Ulcerative Colitis-Associated Colo-rectal Cancer. American Journal of Gastroenterology, 105, 1610-1619. https://doi.org/10.1038/ajg.2010.22
|
[25]
|
Wang, J., Zeng, J., Wang, H., et al. (2016) Genetic Polymorphisms of RAGE and Risk of Ulcerative Colitis in a Chinese Population. Immunology Letters, 170, 88-94. https://doi.org/10.1016/j.imlet.2015.09.003
|
[26]
|
Tahara, T., Shibata, T., Nakamura, M., et al. (2009) Effect of MDR1 Gene Promoter Methylation in Patients with Ulcerative Colitis. International Journal of Molecular Medicine, 23, 521-527. https://doi.org/10.3892/ijmm_00000160
|
[27]
|
Tahara, T., Shibata, T., Nakamura, M., et al. (2009) Promoter Methylation of Protease-Activated Receptor (PAR2) Is Associated with Severe Clinical Phenotypes of Ul-cerative Colitis (UC). Clinical and Experimental Medicine, 9, 125-130. https://doi.org/10.1007/s10238-008-0025-x
|
[28]
|
Hudson, B.I., Stickland, M.H., Futers, T.S., et al. (2001) Effects of Novel Polymorphisms in the RAGE Gene on Transcriptional Regulation and Their Association with Diabetic Reti-nopathy. Diabetes, 50, 1505-1511.
https://doi.org/10.2337/diabetes.50.6.1505
|
[29]
|
Däbritz, J., Friedrichs, F., Weinhage, T., et al. (2011) The Func-tional-374T/A Polymorphism of the Receptor for Advanced Glycation End Products May Modulate Crohn’s Disease. Gastroenterology, 300, G823-G832.
|
[30]
|
Wang, Z.T., Hu, J.J., Fan, R., et al. (2014) RAGE Gene Three Polymor-phisms with Crohn’s Disease Susceptibility in Chinese Han Population. World Journal of Gastroenterology, 20, 2397. https://doi.org/10.3748/wjg.v20.i9.2397
|